论文部分内容阅读
慢性肾小球疾病和尿毒症患者甲状腺功能变化所致的“低T_3、T_4综合征”,国内外已有报告,但是否使用甲状腺激素替代治疗仍有争议。我们应用刺五加注射液治疗取得了满意疗效,现报告如下。一、临床资料按中华肾脏病学会第二届全国学术会议(1985年)修订的诊断标准,临床确诊为肾病Ⅱ型患者。男12例,女12例;平均年龄30.5岁(20～17)。治疗组12例,对照组12例。原发病均为慢性肾炎。治疗方法:治疗组,10％葡萄精250ml加剌五加注射液40ml(黑龙江省完达山制药厂,批号901206)静脉滴注,每日1次;雷公藤多甙片20mg(湖南株州市制药三厂)每日3次。对照组,雷公藤多甙片20mg每天3次,两组疗程均为1周,每周测定尿蛋白量、内生
Chronic glomerular diseases and uremic patients with thyroid function changes caused by “low T_3, T_4 syndrome,” has been reported at home and abroad, but whether or not to use thyroid hormone replacement therapy is still controversial. We applied acanthopanax injection achieved satisfactory results, are as follows. First, the clinical data by the Chinese Society of Nephrology Second National Academic Conference (1985) revised diagnostic criteria, clinically diagnosed as nephropathy type Ⅱ patients. There were 12 males and 12 females with an average age of 30.5 years (20-17). 12 cases in the treatment group and 12 cases in the control group. The primary disease are chronic nephritis. Treatment: The treatment group, 10% grape extract 250ml plus acanthopanax injection 40ml (Wandashan Pharmaceutical Factory in Heilongjiang Province, batch number 901206) intravenous infusion, once daily; Tripterygium glycosides tablets 20mg (Hunan Zhuzhou Pharmaceutical Factory) 3 times a day. The control group, Tripterygium tablets 20mg 3 times a day, two courses of treatment are 1 week, weekly determination of urinary protein, endogenous